NewswireToday - /newswire/ -
Noida, Uttar Pradesh, India, 2011/07/05 - Sales of major insulin and insulin analogues brands is anticipated to grow at a CAGR of around 18% during 2012-2014, providing a boost to the global protein therapeutics market, says RNCOS in its latest research offering - RNCOS.com.
The global protein therapeutics market depends greatly on the sales from insulin and insulin analogues, as the demand for these therapies are high compared to therapies for other diseases. The segment was not only able to weather the effects of the recent economic downturn, but has also picked up pace since the recovery period started. This has been possible due to factors, such as increasing prevalence of diabetes, improving affordability of populations around the world, and the introduction of painless and convenient methods of insulin delivery attracting the consumers. Backed by these supportive factors, the global insulin market is expected to grow at a CAGR of around 18% during 2012-2014, according to our new research report “Global Protein Therapeutics Market Analysis”.
Through in-depth research and prudent analysis of the global protein therapeutics market, we have identified some of the prominent factors that would act as a catalyst for the industry in the future. The report reveals that, the protein therapeutics industry will be driven by volumes of research work being done to improve the efficacy and tackle the immunogenicity issues related to the therapies. Other areas of interest for the industry would be improving the drug delivery methods and devising multi-functional proteins to enhance the profitability of the market.
The report also studies the global protein therapeutics market to give an insight into its various other segments, including Monoclonal Antibodies, Erythropoietins, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor and Follicle Stimulating Hormone. The comprehensive market analysis reveals that, besides insulin, monoclonal antibodies hold a major share in the global protein therapeutics market.
“Global Protein Therapeutics Market Analysis”, provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry. The report incorporates extensive information of the traditional markets and emerging technologies. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution have been thoroughly studied in the report to present a comprehensive view of the global protein therapeutics market. The report has thoroughly examined the current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.